Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer

Zsófia Sztupinszki, Miklós Dióssy, Marcin Krzystanek, +7

npj Breast Cancer

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Lívia Rojkó, Lilla Reiniger, Vanda Téglási, +9

Journal of Cancer Research and Clinical Oncology

MedicineImmunologyPathologyImmune Checkpoint InhibitorLung Cancer Patients +6

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors

Miklós Dióssy, Lilla Reiniger, Zsófia Sztupinszki, +15

Annals of Oncology

Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib

Ambrus Gángó, Donát Alpár, Bence Gálik, +18

International Journal of Cancer

Lack of Angiogenesis in Experimental Brain Metastases

Edina Bugyik, Katalin Dezső, Lilla Reiniger, +6

Journal of Neuropathology & Experimental Neurology

Epithelial Cell LinesBrain MetastasesExperimental Brain MetastasesPathologyTumor Biology +14

Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma

Csaba Bödör, Donát Alpár, Dóra Marosvári, +19

Journal of Neuropathology & Experimental Neurology

Tumor InnervationImmunologyPathologyImmunophenotypingImmunotherapy +15

Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis

Vanda Téglási, Lilla Reiniger, Katalin Fábián, +10

Neuro-Oncology

Comprehensive Analysis of Circulating miRNAs in the Plasma of Patients With Pituitary Adenomas

Kinga Németh, Ottó Darvasi, István Likó, +9

The Journal of Clinical Endocrinology & Metabolism

The cut‐off levels of CD23 expression in the differential diagnosis of MCL and CLL

Gábor Barna, Lilla Reiniger, Péter Tátrai, +2

Hematological Oncology

PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis

Vanda Téglási, Orsolya Pipek, Rita Lózsa, +10

Clinical Lung Cancer

Cancer ImmunosurveillancePd-l1 ExpressionImmunologyBrain MetastasisImmune Checkpoint Inhibitor +5